IRIS Biosensor Platform

About Lodestone Biomedical

Lodestone Biomedical is a private, pre-revenue diagnostics company spun out of Dartmouth College in 2020, headquartered in Lebanon, New Hampshire. The company is developing a proprietary biosensing platform designed to detect and monitor immune responses within the tumor microenvironment in real-time, providing a novel tool for preclinical cancer research and drug development. Led by a team with deep expertise in biomedical device R&D, Lodestone aims to address a critical bottleneck in oncology research by enabling faster, more confident decision-making in early-stage compound screening. Its technology represents a platform approach to understanding disease processes at a cellular level, with the potential to significantly accelerate the discovery of new cancer treatments.

Therapeutic Areas